2 min readfrom Frontiers in Marine Science | New and Recent Articles

Jellyfish bioactive compounds fueling marine biotechnology in blue economy and biomedicine

Our take

Jellyfish, often dismissed as marine nuisances, are emerging as vital sources of bioactive compounds with significant potential in biomedicine and marine biotechnology. This review examines the properties and applications of key jellyfish-derived biomolecules, including collagen, peptides, and polysaccharides, highlighting their ecological importance and technological promise. Notably, collagen extraction from species such as Cassiopea andromeda demonstrates both efficiency and biocompatibility, paving the way for innovative biomedical solutions. By leveraging jellyfish biomass within the blue economy framework, we can address pressing medical needs while promoting sustainable practices.
Jellyfish bioactive compounds fueling marine biotechnology in blue economy and biomedicine

The recent review on jellyfish bioactive compounds opens up a fascinating dialogue on the untapped potential of these often-maligned creatures. Traditionally viewed as nuisances, jellyfish are now recognized as valuable sources of biomolecules that could significantly impact biomedical sciences and marine biotechnology. This shift in perception is crucial, especially as we face increasing environmental challenges and seek sustainable alternatives within the blue economy. By exploring the properties, extraction, and applications of jellyfish-derived compounds, such as collagen, peptides, and sulfated polysaccharides, this review highlights how jellyfish can contribute to both ecological balance and innovative biotechnological solutions. For instance, the article “Engaging small-scale fishers in a circular bioeconomy: valorization of Rhizostoma pulmo (Macri, 1778) jellyfish bycatch for sustainable collagen production” provides insight into how bycatch from jellyfish can be transformed into valuable resources, thus creating a sustainable loop that benefits both the environment and the fishing community.

The review emphasizes the ecological role of jellyfish, particularly during bloom events in regions like the Mediterranean. Species such as Rhizostoma pulmo have garnered attention not only for their ecological impact but also for their potential as bioresources. The occurrence of jellyfish blooms is often perceived negatively, yet these events can serve as a reminder of the complex interplay between marine life and environmental conditions. By addressing the implications of these blooms, the review encourages a more nuanced understanding of jellyfish within marine ecosystems. In doing so, it paves the way for innovative approaches to bioprospecting, where jellyfish can be seen as contributors to marine health and sources of high-impact biomolecules. This perspective aligns with our broader mission of promoting ocean stewardship and recognizing the shared responsibility we have in managing marine resources sustainably.

Among the bioactive compounds derived from jellyfish, collagen emerges as a particularly promising candidate, supported by advancements in extraction protocols and its compatibility with manufacturing processes. The review notes that aquaculture-reared Cassiopea andromeda may yield collagen comparable to wild populations while boasting enhanced antioxidant profiles. This finding not only demonstrates the feasibility of sustainable aquaculture practices but also highlights the potential for jellyfish to be cultivated as biofactories for valuable biomaterials. As the demand for biocompatible materials in medicine and other fields continues to grow, the potential of jellyfish-derived collagen becomes increasingly relevant. The insights shared in the review echo sentiments from other articles, such as the one on engaging small-scale fishers, underscoring the interconnectedness of marine biotechnology and sustainable practices.

However, while collagen may be leading the charge, compounds like peptides and sulfated polysaccharides still require further research and standardization before they can be widely utilized. This transitional phase is critical, as it presents both challenges and opportunities for innovation. The review encourages ongoing research into these compounds, advocating for a collaborative approach to their development. As we look forward, it is essential to consider how we can integrate these findings into broader biotechnological frameworks that prioritize sustainability and environmental health. The question remains: how can we ensure that the biotechnological advancements derived from jellyfish not only meet medical needs but also align with our commitments to ocean stewardship and ecological integrity?

In conclusion, the exploration of jellyfish bioactive compounds represents a significant step towards recognizing the value of marine organisms in the context of the blue economy. As we advance our understanding and utilization of these resources, we must remain vigilant in our efforts to balance innovation with ecological responsibility. The path ahead is promising, but it requires a collective commitment to harnessing the potential of our oceans sustainably.

Jellyfish, often primarily perceived by the public as a marine nuisance, represent an increasingly valuable and sustainable source of diverse biomolecules with significant potential for the biomedical sciences, in addition to their crucial ecological role within marine ecosystems. This review explores the properties, extraction and applications of key jellyfish-derived compounds, including collagen, peptides, sulfated polysaccharides, glycoproteins and venom components. The relevance of jellyfish as a bioresource is underscored by episodic bloom events in the Mediterranean, where species such as Rhizostoma pulmo (Macri, 1778) have been reported in affected coastal areas. This review provides a critical synthesis of current advances in the extraction, characterization, and biotechnological exploitation of jellyfish-derived bioactive compounds, on ecologically and biotechnologically relevant Mediterranean species, which collectively represent accessible and high-impact targets for marine bioprospecting. Evidence from non-Mediterranean species is also discussed for comparative purposes to contextualize conserved biochemical features across different biogeographical regions. Among jellyfish-derived biomolecules, collagen emerges as the most technologically mature and translationally advanced compound, supported by reproducible extraction protocols, preserved triple-helical structure, cytocompatibility, and compatibility with pre-GMP manufacturing workflows. Recent studies further demonstrate that aquaculture-reared Cassiopea andromeda (Forsskål, 1775) may achieve collagen yields comparable to wild populations (~40–46%) while exhibiting enhanced antioxidant profiles, supporting the feasibility of controlled biofactory approaches. In contrast, peptides, sulfated polysaccharides, and venom components display promising biological activities but remain at earlier stages of technological readiness, requiring further standardization, structure–function elucidation, and regulatory development. Within circular and blue bioeconomy frameworks, jellyfish biomass—particularly from invasive or bloom-forming species such as C. andromeda—offers a concrete opportunity to unlock novel therapeutic solutions and advanced biomaterials, addressing critical unmet medical needs and offering a sustainable alternative to traditional biomedical resources.

Read on the original site

Open the publisher's page for the full experience

View original article

Related Articles

Tagged with